Dr Reddys Laboratories Cash Flow Annual

Trade
BSE: 500124 | NSE: DRREDDY | ISIN: INE089A01023 | Sector: Biotechnology & Drugs
5,990.40 -94.05 (-1.55%)Updated : 18 Jun 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 7,201.006,048.503,061.402,883.50
Depreciation/ Depletion 1,470.001,250.201,165.201,228.80
Non- Cash Items -104.80445.70710.20858.40
Changesin Working Capital -4,022.90-1,856.90-2,126.00-1,400.40
Cashfrom Operating Activities 4,543.305,887.502,810.803,570.30
Capital Expenditures -2,743.50-1,886.60-1,904.90-1,256.10
Other Investing Cash Flow Items Total -1,284.80-2,250.70-733.80-1,009.90
Cashfrom Investing Activities -4,028.30-4,137.30-2,638.70-2,266.00
Financing Cash Flow Items -226.60-185.30-134.50-132.10
Total Cash Dividends Paid -664.80-497.90-414.60-414.70
Issuance( Retirement)of Stock Net 80.5036.8033.40-92.40
Issuance( Retirement)of Debt Net 434.60-2,039.70273.50609.40
Cashfrom Financing Activities -376.30-2,686.10-242.20-29.80
Foreign Exchange Effects -5.9028.6073.3011.30
Net Changein Cash 132.80-907.303.201,285.80
Cash Interest Paid 226.60185.30134.50132.10
Cash Taxes Paid 2,004.701,071.40743.70571.60
*All figures in crores except per share values
Recommended For You
Trending Stocks
491.85+14.50(3.04%)
3,589.00+61.40(1.74%)
12,576.20-275.00 (-2.14%)
181.15-1.90 (-1.04%)
HomeMarketsPremiumInstant LoanGet App